Kwiat Moria

Avg. Two Year Performance

No purchase track record
82% Avg. Sale Return
35% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return12%22%33%38%82%
Sale Success Rate1 of 11 of 11 of 11 of 11 of 1

Pluristem Therapeutics, Inc.

Drugs » Biotechnology

Director:

Holdings: 57.36K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--